Scoop has an Ethical Paywall
ElderCare Appoints New Director to the Board
MEDIA RELEASE
ElderCare Appoints New Director to
the Board
Auckland – March 14, 2002 – Listed
healthcare provider, ElderCare New Zealand (NZSE: ELD) today
announced that it has appointed Dr Clint Teague, managing
partner of the recently acquired Medical Laboratory
Wellington and Nelson Diagnostic Laboratories, to its board
of directors.
Said ElderCare’s CEO and director, Alan Clarke, “We are very pleased with the opportunity to have Dr Teague join the board. He brings a wealth of experience in the pathology industry to the company, and as ElderCare’s growth unfolds we will draw on this medical experience.”
The appointment follows a successful capital raising last year, and the acquisition of the Wellington and Nelson pathology businesses in January 2002.
ENDS
Company Background
ElderCare New Zealand
Limited (NZSE: ELD) is a medical and healthcare service
provider. The company owns a substantial portfolio of
nursing homes, assisted living, assessment and
rehabilitation facilities throughout New Zealand, and two
pathology businesses. These offer an array of specialised
services to cater for the healthcare needs of a broad range
of New Zealanders. The company has embarked on a programme
that will see it expand its operations into other fee income
generating businesses in the wider healthcare sector.
Skoltech: Scientists Reinvent Physical Laws Governing Formation Of Snowflakes, Raindrops, And Saturn’s Rings
Trademe: Trash To Treasure - Kiwi Make The Most Of Unwanted Christmas Gifts 
Financial Markets Authority: FMA Seeks Clarity From High Court On Use Of Eligible Investor Certificates In Wholesale Investment Sector
Scion: Scion’s Novel Internship Model Connects Talent With Industry
Financial Markets Authority: Westpac Admits To Misleading Representations That Resulted In $6.35m In Overcharges
Bill Bennett: Download Weekly - Review Of 2024
